Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy.

Levene M, Bain MD, Moran NF, Nirmalananthan N, Poulton J, Scarpelli M, Filosto M, Mandel H, MacKinnon AD, Fairbanks L, Pacitti D, Bax BE.

J Clin Med. 2019 Apr 5;8(4). pii: E457. doi: 10.3390/jcm8040457.

2.

Reversible Cerebral White Matter Abnormalities in Homocystinuria.

Ismayilova N, MacKinnon AD, Mundy H, Fallon P.

JIMD Rep. 2019;44:115-119. doi: 10.1007/8904_2018_135. Epub 2018 Sep 6.

3.

GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.

Ismayilova N, Hacohen Y, MacKinnon AD, Elmslie F, Clarke A.

Eur J Paediatr Neurol. 2018 Nov;22(6):1161-1164. doi: 10.1016/j.ejpn.2018.02.002. Epub 2018 Feb 9.

PMID:
30115503
4.

Identifying preclinical vascular dementia in symptomatic small vessel disease using MRI.

Lambert C, Zeestraten E, Williams O, Benjamin P, Lawrence AJ, Morris RG, Mackinnon AD, Barrick TR, Markus HS.

Neuroimage Clin. 2018 Jun 20;19:925-938. doi: 10.1016/j.nicl.2018.06.023. eCollection 2018.

5.

Lacunar Infarcts, but Not Perivascular Spaces, Are Predictors of Cognitive Decline in Cerebral Small-Vessel Disease.

Benjamin P, Trippier S, Lawrence AJ, Lambert C, Zeestraten E, Williams OA, Patel B, Morris RG, Barrick TR, MacKinnon AD, Markus HS.

Stroke. 2018 Mar;49(3):586-593. doi: 10.1161/STROKEAHA.117.017526. Epub 2018 Feb 2.

6.

A runny nose.

Kirk T, Kanagaratnam M, MacKinnon AD, Nitkunan A.

Pract Neurol. 2018 Jun;18(3):238-239. doi: 10.1136/practneurol-2017-001804. Epub 2018 Jan 26. No abstract available.

PMID:
29374090
7.

Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients.

Nannucci S, Rinnoci V, Pracucci G, MacKinnon AD, Pescini F, Adib-Samii P, Bianchi S, Dotti MT, Federico A, Inzitari D, Markus HS, Pantoni L.

PLoS One. 2018 Jan 25;13(1):e0190878. doi: 10.1371/journal.pone.0190878. eCollection 2018.

8.

Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.

Zeestraten EA, Lawrence AJ, Lambert C, Benjamin P, Brookes RL, Mackinnon AD, Morris RG, Barrick TR, Markus HS.

Neurology. 2017 Oct 31;89(18):1869-1876. doi: 10.1212/WNL.0000000000004594. Epub 2017 Oct 4.

9.

Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.

Williams OA, Zeestraten EA, Benjamin P, Lambert C, Lawrence AJ, Mackinnon AD, Morris RG, Markus HS, Charlton RA, Barrick TR.

Neuroimage Clin. 2017 Aug 15;16:330-342. doi: 10.1016/j.nicl.2017.08.016. eCollection 2017.

10.

The use of diffusion weighted imaging to evaluate pathology outside the brain parenchyma in neuroimaging studies.

Benjamin P, Khan F, MacKinnon AD.

Br J Radiol. 2017 Apr;90(1072):20160821. doi: 10.1259/bjr.20160821. Epub 2017 Feb 14. Review.

11.

Prominent cognitive decline and behavioural disturbance in late-onset Alexander disease.

Garcia-Reitboeck P, MacKinnon AD, McEntagart M, Lambert C, Edwards M, Omer S.

J Neurol Sci. 2015 Oct 15;357(1-2):319-21. doi: 10.1016/j.jns.2015.07.038. Epub 2015 Jul 26. No abstract available.

PMID:
26285664
12.

Progression of MRI markers in cerebral small vessel disease: Sample size considerations for clinical trials.

Benjamin P, Zeestraten E, Lambert C, Ster IC, Williams OA, Lawrence AJ, Patel B, MacKinnon AD, Barrick TR, Markus HS.

J Cereb Blood Flow Metab. 2016 Jan;36(1):228-40.

13.

7 Tesla MRI in cerebral small vessel disease.

Benjamin P, Viessmann O, MacKinnon AD, Jezzard P, Markus HS.

Int J Stroke. 2015 Jul;10(5):659-64. doi: 10.1111/ijs.12490. Epub 2015 Apr 6. Review.

PMID:
25845965
14.

Systemic Lupus Erythematosus Presenting as Orbital Myositis.

Jenkins PO, Soper C, MacKinnon AD, O'Sullivan E, Nitkunan A.

Neuroophthalmology. 2014 Aug 8;38(5):264-267. eCollection 2014.

15.

Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease.

Benjamin P, Lawrence AJ, Lambert C, Patel B, Chung AW, MacKinnon AD, Morris RG, Barrick TR, Markus HS.

Neuroimage Clin. 2014 May 21;4:828-37. doi: 10.1016/j.nicl.2014.05.009. eCollection 2014.

16.

Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.

Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR, Markus HS.

PLoS One. 2013 Apr 22;8(4):e61014. doi: 10.1371/journal.pone.0061014. Print 2013. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/bbde462e-c699-4c4d-9b61-050c7e6e5ce3.

17.

Cerebral microbleeds and cognition in patients with symptomatic small vessel disease.

Patel B, Lawrence AJ, Chung AW, Rich P, Mackinnon AD, Morris RG, Barrick TR, Markus HS.

Stroke. 2013 Feb;44(2):356-61. doi: 10.1161/STROKEAHA.112.670216. Epub 2013 Jan 15.

PMID:
23321452
18.

Localization of bilateral auditory hallucinations and correlation to imaging in posterior circulation stroke.

Galtrey CM, MacKinnon AD, Pereira AC.

Neurologist. 2012 Nov;18(6):418-22. doi: 10.1097/NRL.0b013e3182761d19. Review.

PMID:
23114681
19.

Ambulatory transcranial Doppler cerebral embolic signal detection in symptomatic and asymptomatic carotid stenosis.

Mackinnon AD, Aaslid R, Markus HS.

Stroke. 2005 Aug;36(8):1726-30. Epub 2005 Jul 21.

PMID:
16040594
20.

Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study.

Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS.

Stroke. 2004 Sep;35(9):2150-4. Epub 2004 Jul 8.

PMID:
15243147

Supplemental Content

Loading ...
Support Center